meglumine has been researched along with Acute Confusional Senile Dementia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Back, TG; Chen, AW; Chen, SRW; Estillore, JP; Sun, B; Wang, R; Yao, J | 1 |
1 other study(ies) available for meglumine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Carvedilol; Disease Models, Animal; Humans; Meglumine; Mice; Mutation; Neurons; Ryanodine Receptor Calcium Release Channel; Specimen Handling; Time Factors | 2021 |